Keywords
How to Cite
Abstract
The aim of this study was to develop and introduce a new diagnostic method diagnosing and controlling the effective treatment of hepatic steatosis in patients with type 2 diabetes
into clinical practice. Materials and Methods. Ultrasound diagnostics (USD) of abdominal organs (AO) was performed in 949 patients with fatty liver disease according to Hamaguchi
criteria. The attenuation coefficient measurement (ACM) was realized in right and left lobes of the liver by Soneus P7 device (Ultrasign, Ukraine) with a 1-6 MHz convex transducer. Computer tomography (CT) data of AO in native phase and controlled attenuation parameter (CAP) by Fibroscan (Echosens, France) were assessed in 142 patients for determining the diagnostic accuracy of ACM. Results. The study substantiates the expedience of ACM application in patients with hepatic steatosis. Conclusions. It is proved that ACM results are correlated with CT and CAP indices. ACM can be used as a new noninvasive method for diagnosing hepatic steatosis. This method allows to quantify the degree of steatosis progression.
References
2. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease // J. Hepatol. — 2016. — Vol. 64. — P. 1388-1402.
3. Кобиляк Н.М., Динник О.Б., Кирієнко Д.В. Сучасні підходи до діагностики та скринінгу метаболічних порушень у хворих із неалкогольною жировою хворобою печінки // Міжнародний ендокринологічний журнал. — 2015. — № 5 (69). — С. 89-99. (Kobylyak N.M., Dynnyk O.B., Kirienko D.V. Modern approach to diagnosis and screening of metabolic disorders in patients with nonalcoholic fatty liver disease // Mizhnarodnyy endokrynolohichnyy zhurnal. — 2015. — № 5 (69). — P. 89-99).
4. Боднар П.М., Динник О.Б., Михальчишин Г.П., Берегова Т.В. Оцінка еластографії в діагностиці експериментальної неалкогольної жирової хвороби печінки // Журнал НАМН
України. — 2011. — Т. 17, № 4. — C. 422-430. (Bodnar P.M., Dynnyk O.B., Mykhal’chyshyn H.P., Beregova T.V. Elastography estimation of shear wave in diagnosis of experimental nonalcoholic fatty liver disease // Zhurnal NAMN Ukrayiny. — 2011. — Vol. 17, № 4. — C. 422-430).
5. Foucher J., Castéra L., Bernard P.H., Adhoute X., Laharie D., Bertet J., Couzigou P., de Lédinghen V. Prevalence and factors associated with failure of liver stiffness measurement using
FibroScan in a prospective study of 2114 examinations // Eur. J. Gastroenterol. Hepatol. — 2006. — Vol. 18, № 4. — P. 411-412.
6. Iwasaki M., Takada Y., Hayashi M., Minamiguchi S., Haga H., Maetani Y., Fujii K., Kiuchi T., Tanaka K. Noninvasive evaluation of graft steatosis in living donor liver transplantation //
Transplantation. — 2004. — Vol. 78, № 10. — P. 1501-1505.
7. Mazhar S.M., Shiehmorteza M., Sirlin C.B. Noninvasive assessment of hepatic steatosis // Clin. Gastroenterol. Hepatol. — 2009. — Vol. 7, № 2. — P. 135-140.
8. Longo R., Pollesello P., Ricci C., Masutti F., Kvam B.J., Bercich L., Crocè L.S., Grigolato P., Paoletti S., de Bernard B. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis // J. Magn. Reson. Imaging. — 1995. — Vol. 5, № 3. — P. 281-285.
9. Szczepaniak L.S., Nurenberg P., Leonard D., Browning J.D., Reingold J.S., Grundy S., Hobbs H.H., Dobbins R.L. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population // Am. J. Physiol. Endocrinol. Metab. — 2005. — Vol. 288, № 2. — P. 462-468.
10. Шерлок Ш., Дули Дж. Заболевания печени и желчных путей. — М.: Гэотар Медицина, 1999. — 864 с. (Sherlock Sh., Dooley J. Diseases of the liver and biliary systemsa. — Moscow: Geotar Meditsina, 1999. — 864 p.).